Veracyte (VCYT) Inventory (2012 - 2025)

Veracyte has reported Inventory for 14 years, with the latest figure at $20.5 million in Q4 2025.

• Inventory for Q4 2025 came in at $20.5 million, down 5.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.5 million (down 5.54% YoY), and the FY2025 annual result was $20.5 million, down 5.54% from the prior year.
• Inventory grew to $20.5 million in Q4 2025, from $20.3 million in the prior quarter.
• Over five years, Inventory peaked at $25.0 million in Q2 2025 and troughed at $6.3 million in Q1 2021.
• A 5-year average of $15.8 million and a median of $15.2 million in 2022 frame the typical range for Inventory.
• The widest annual swing landed in 2021, when Inventory surged 141.04%; it then retreated 20.74% in 2023.
• A 5-year view of Inventory shows it stood at $11.2 million in 2021, then gained by 27.34% to $14.3 million in 2022, then advanced by 12.83% to $16.1 million in 2023, then soared by 34.86% to $21.8 million in 2024, then dropped by 5.54% to $20.5 million in 2025.
• Per Business Quant data, the three most recent Inventory figures were $20.5 million in Q4 2025, $20.3 million in Q3 2025, and $25.0 million in Q2 2025.